The importance of prognostic factors in advanced prostate cancer

M. S. Soloway

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Three factors were identified in a multivariate analysis of prognostic factors in men with metastatic prostate cancer as significantly associated with their progression-free survival: 1) extent of disease on the bone scan, 2) pretreatment serum testosterone, and 3) performance status. Men with less than six bone metastases, a pretreatment testosterone > 300 ng/100 ml, and an excellent performance status will have a progression-free survival much longer than a man with more extensive bone metastases, a low testosterone prior to androgen deprivation, and a poor performance status. This information should be used to ensure proper stratification in randomized trials. It may also be helpful in identifying the patient unlikely to be helped by our current treatment. Such patient should be considered for alternative approaches with the aim of improving survival.

Original languageEnglish
Pages (from-to)1017-1021
Number of pages5
JournalCancer
Volume66
Issue number5 SUPPL.
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Testosterone
Prostatic Neoplasms
Disease-Free Survival
Neoplasm Metastasis
Bone and Bones
Bone Diseases
Androgens
Multivariate Analysis
Survival
Serum
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Soloway, M. S. (1990). The importance of prognostic factors in advanced prostate cancer. Cancer, 66(5 SUPPL.), 1017-1021.

The importance of prognostic factors in advanced prostate cancer. / Soloway, M. S.

In: Cancer, Vol. 66, No. 5 SUPPL., 01.01.1990, p. 1017-1021.

Research output: Contribution to journalArticle

Soloway, MS 1990, 'The importance of prognostic factors in advanced prostate cancer', Cancer, vol. 66, no. 5 SUPPL., pp. 1017-1021.
Soloway MS. The importance of prognostic factors in advanced prostate cancer. Cancer. 1990 Jan 1;66(5 SUPPL.):1017-1021.
Soloway, M. S. / The importance of prognostic factors in advanced prostate cancer. In: Cancer. 1990 ; Vol. 66, No. 5 SUPPL. pp. 1017-1021.
@article{d02a7d7d2aac4080bce6d143546f033c,
title = "The importance of prognostic factors in advanced prostate cancer",
abstract = "Three factors were identified in a multivariate analysis of prognostic factors in men with metastatic prostate cancer as significantly associated with their progression-free survival: 1) extent of disease on the bone scan, 2) pretreatment serum testosterone, and 3) performance status. Men with less than six bone metastases, a pretreatment testosterone > 300 ng/100 ml, and an excellent performance status will have a progression-free survival much longer than a man with more extensive bone metastases, a low testosterone prior to androgen deprivation, and a poor performance status. This information should be used to ensure proper stratification in randomized trials. It may also be helpful in identifying the patient unlikely to be helped by our current treatment. Such patient should be considered for alternative approaches with the aim of improving survival.",
author = "Soloway, {M. S.}",
year = "1990",
month = "1",
day = "1",
language = "English",
volume = "66",
pages = "1017--1021",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5 SUPPL.",

}

TY - JOUR

T1 - The importance of prognostic factors in advanced prostate cancer

AU - Soloway, M. S.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Three factors were identified in a multivariate analysis of prognostic factors in men with metastatic prostate cancer as significantly associated with their progression-free survival: 1) extent of disease on the bone scan, 2) pretreatment serum testosterone, and 3) performance status. Men with less than six bone metastases, a pretreatment testosterone > 300 ng/100 ml, and an excellent performance status will have a progression-free survival much longer than a man with more extensive bone metastases, a low testosterone prior to androgen deprivation, and a poor performance status. This information should be used to ensure proper stratification in randomized trials. It may also be helpful in identifying the patient unlikely to be helped by our current treatment. Such patient should be considered for alternative approaches with the aim of improving survival.

AB - Three factors were identified in a multivariate analysis of prognostic factors in men with metastatic prostate cancer as significantly associated with their progression-free survival: 1) extent of disease on the bone scan, 2) pretreatment serum testosterone, and 3) performance status. Men with less than six bone metastases, a pretreatment testosterone > 300 ng/100 ml, and an excellent performance status will have a progression-free survival much longer than a man with more extensive bone metastases, a low testosterone prior to androgen deprivation, and a poor performance status. This information should be used to ensure proper stratification in randomized trials. It may also be helpful in identifying the patient unlikely to be helped by our current treatment. Such patient should be considered for alternative approaches with the aim of improving survival.

UR - http://www.scopus.com/inward/record.url?scp=0024996407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024996407&partnerID=8YFLogxK

M3 - Article

VL - 66

SP - 1017

EP - 1021

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5 SUPPL.

ER -